Peptide binding to Geminin and inhibitory for DNA replication

Area of Science:

• Molecular Biology
• Cell Cycle Regulation
• Cancer Therapeutics

Background:

• Geminin is a protein that inhibits DNA replication by binding to Cdt1, ensuring DNA replication occurs only once per cell cycle.
• Dysregulation of cell cycle control is a hallmark of cancer, making proteins like Geminin potential therapeutic targets.

Purpose of the Study:

• To identify a specific peptide that binds to Geminin.
• To investigate whether this peptide can modulate Geminin's function in altering DNA replication activity.
• To assess the therapeutic potential of targeting Geminin in human cancer cells.

Main Methods:

• Phage display library screening was employed to identify peptides binding to Geminin.
• Peptide-Geminin binding was mapped to the 31-111 amino acid residues of Geminin.
• The identified peptide was delivered into HCT116 human colon cancer cells to assess its effect on DNA replication.

Main Results:

• A specific peptide sequence was identified that binds to the 31-111 amino acid region of Geminin.
• Nuclear delivery of this peptide led to the suppression of BrdU incorporation in HCT116 cells, indicating inhibition of DNA replication.
• These findings demonstrate that Geminin's DNA replication inhibitory function can be modulated by specific peptide interactions.

Conclusions:

• Geminin plays a critical role in controlling DNA replication, and its function can be targeted by specific peptides.
• The identified peptide offers a novel tool for studying Geminin's function and its role in cancer.
• Geminin represents a promising therapeutic target for the development of novel anti-cancer strategies.